Regeneron Pharmaceuticals (REGN)
Free Cash Flow
$334.30M
Quarterly · Period ending: · USD
REGN Free Cash Flow
Latest reported$334.30Mperiod ending
Latest reported$334.30Mperiod ending
REGN Quarterly Free Cash Flow (-$2.80M → $334.30M)
Quarterly free cash flow
High-resolution chart · PNG
REGN free cash flow history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Free Cash Flow (USD) |
|---|---|
| 334,300,000 | |
| 848,300,000 | |
| 922,000,000 | |
| 1,417,300,000 | |
| 967,600,000 | |
| 773,600,000 | |
| 995,800,000 | |
| 1,107,600,000 | |
| 143,100,000 | |
| 1,350,700,000 | |
| 776,200,000 | |
| 938,300,000 | |
| 909,400,000 | |
| 1,189,400,000 | |
| 1,567,700,000 | |
| 486,400,000 | |
| 410,800,000 | |
| 1,959,900,000 | |
| 2,217,600,000 | |
| 3,280,400,000 | |
| 478,200,000 | |
| 553,200,000 | |
| 1,069,600,000 | |
| -407,500,000 | |
| 813,500,000 | |
| 527,900,000 | |
| 648,400,000 | |
| 435,600,000 | |
| 93,700,000 | |
| 822,700,000 | |
| 643,300,000 | |
| 346,700,000 | |
| 282,600,000 | |
| 539,400,000 | |
| 459,300,000 | |
| 355,179,000 | |
| -85,419,000 | |
| 305,440,000 | |
| 227,424,000 | |
| 532,473,000 | |
| 260,663,000 | |
| -59,105,000 | |
| 104,044,000 | |
| 746,754,000 | |
| 17,938,000 | |
| -215,889,000 | |
| 80,633,000 | |
| 84,552,000 | |
| 265,539,000 | |
| -11,295,000 | |
| 207,805,000 | |
| 60,764,000 | |
| 93,711,000 | |
| 65,045,000 | |
| 78,023,000 | |
| -12,630,000 | |
| -91,249,000 | |
| -98,096,000 | |
| -61,606,000 | |
| -55,633,000 | |
| -48,914,000 | |
| -32,746,000 | |
| -73,961,000 | |
| 138,566,000 | |
| -35,206,000 | |
| -32,744,000 | |
| -68,720,000 | |
| -32,153,000 | |
| -36,559,000 | |
| -32,116,000 | |
| -51,580,000 | |
| -50,874,000 | |
| -545,000 | |
| -20,944,000 | |
| 40,087,000 | |
| -15,392,000 | |
| -5,334,000 | |
| -10,435,000 | |
| 52,095,000 | |
| -15,448,000 | |
| -21,015,000 | |
| 4,632,000 | |
| -20,198,000 | |
| -16,714,000 | |
| -30,121,000 | |
| 31,773,000 | |
| -13,526,000 | |
| -5,900,000 | |
| 15,910,000 | |
| -19,567,000 | |
| -29,714,000 | |
| 58,424,000 | |
| -45,688,000 | |
| -18,811,000 | |
| -46,197,000 | |
| -32,172,000 | |
| -36,470,000 | |
| -30,054,000 | |
| -20,254,000 | |
| -23,658,000 |